Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing deoxyribonucleic acid (DNA) damage-dependent cell cycle arrest
出版年份 2023 全文链接
标题
Cucurbitacin B suppresses hepatocellular carcinoma progression through inducing deoxyribonucleic acid (DNA) damage-dependent cell cycle arrest
作者
关键词
-
出版物
PHYTOMEDICINE
Volume -, Issue -, Pages 155177
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.phymed.2023.155177
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An Innovative Approach for Formulation of Rutin Tablets Targeted for Colon Cancer Treatment
- (2023) Aliaa Ismail et al. AAPS PHARMSCITECH
- DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21
- (2023) Yingying Tian et al. BIOCHEMICAL PHARMACOLOGY
- Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B
- (2023) Shuanghong Yin et al. PHYTOMEDICINE
- Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells
- (2022) Laxminarayan Rawat et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
- (2022) Yang Liu et al. ACS Central Science
- Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy
- (2022) Tingting Chen et al. International Journal of Nanomedicine
- Atezolizumab plus bevacizumab versus nivolumab as first‐line treatment for advanced or unresectable hepatocellular carcinoma: A cost‐effectiveness analysis
- (2022) Yan Li et al. CANCER
- Trigonelline, a plant derived alkaloid prevents ultraviolet-B-induced oxidative DNA damage in primary human dermal fibroblasts and BALB/c mice via modulation of phosphoinositide 3-kinase-Akt-Nrf2 signalling axis
- (2022) Malik A. Tanveer et al. EXPERIMENTAL GERONTOLOGY
- Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics
- (2022) Shu Dai et al. PHARMACOLOGICAL RESEARCH
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway
- (2021) Xiaoli Wang et al. ANTI-CANCER DRUGS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Autism-associated vigilin depletion impairs DNA damage repair
- (2021) Shahid Banday et al. MOLECULAR AND CELLULAR BIOLOGY
- Synthesis and in vitro antitumour activity of 4(R)-methyl-3-O-phosphonomethyl-α-l-threose nucleosides
- (2021) Feng-Wu Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
- (2019) Tala M. Abu Samaan et al. Biomolecules
- ATR/CHK1 inhibitors and cancer therapy
- (2018) Zhaojun Qiu et al. RADIOTHERAPY AND ONCOLOGY
- PTEN Activation by DNA Damage Induces Protective Autophagy in Response to Cucurbitacin B in Hepatocellular Carcinoma Cells
- (2016) Yanan Niu et al. Oxidative Medicine and Cellular Longevity
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- Recent analytical approaches in quality control of traditional Chinese medicines—A review
- (2009) Yong Jiang et al. ANALYTICA CHIMICA ACTA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now